The prominent role of a CDR1 somatic hypermutation for convergent IGHV3-53/3-66 antibodies in binding to SARS-CoV-2

被引：8
|
作者：
Tian, Xiaolong [1 ]
Zhu, Xiaoyi [1 ]
Song, Wenping [1 ]
Yang, Zhenlin [2 ,3 ,4 ]
Wu, Yanling [1 ,2 ]
Ying, Tianlei [1 ,2 ,4 ]
机构：
[1] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, MOE NHC Key Lab Med Mol Virol, Shanghai 200032, Peoples R China
[2] Shanghai Engn Res Ctr Synthet Immunol, Shanghai 200032, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai, Peoples R China
[4] Shanghai Key Lab Lung Inflammat & Injury, Shanghai 200032, Peoples R China
来源：
EMERGING MICROBES & INFECTIONS | 2022年 / 11卷 / 01期
基金：
国家重点研发计划;
关键词：
SARS-CoV-2; monoclonal antibody; somatic hypermutation; IGHV3-53; antibody affinity;
D O I：
10.1080/22221751.2022.2063074
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
In the fight against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), monoclonal antibodies (mAbs) serve as key strategies for the rapid prevention and treatment of COVID-19. However, analysis to fully characterize functional SARS-CoV-2 mAbs is still needed. In this study, by interrogating 1,695 published or patented mAbs of human origin and validated SARS-CoV-2-binding potency, we found a highly preferential usage of IGHV3-53/3-66 germline genes that was then revealed as a distinct selectivity of SARS-CoV-2-induced humoral immunity across other coronaviruses. Moreover, among the rare somatic hypermutations, we identified a novel mutation signature of F27 to I, L, or V with high frequency, which was located in the CDR1 region of the heavy chain among IGHV3-53/3-66-encoded antibodies. This convergent mutation contributed to improving SARS-CoV-2 binding affinity and may advance our knowledge of the humoral immunity to SARS-CoV-2.
引用
收藏
页码：1186 / 1190
页数：5
相关论文
共 31 条
  • [21] VH3-53/66-Class RBD-Specific Human Monoclonal Antibody iB20 Displays Cross-Neutralizing Activity against Emerging SARS-CoV-2 Lineages
    Kulemzin, Sergey, V
    Sergeeva, Maria, V
    Baranov, Konstantin O.
    Gorchakov, Andrey A.
    Guselnikov, Sergey, V
    Belovezhets, Tatyana N.
    Volkova, Olga Yu
    Najakshin, Alexander M.
    Chikaev, Nikolai A.
    Danilenko, Daria M.
    Taranin, Alexander, V
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (06):
  • [22] A Putative Role of de-Mono-ADP-Ribosylation of STAT1 by the SARS-CoV-2 Nsp3 Protein in the Cytokine Storm Syndrome of COVID-19
    Claverie, Jean-Michel
    VIRUSES-BASEL, 2020, 12 (06):
  • [23] Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3
    Huang, Min
    Wu, Lili
    Zheng, Anqi
    Xie, Yufeng
    He, Qingwen
    Rong, Xiaoyu
    Han, Pu
    Du, Pei
    Han, Pengcheng
    Zhang, Zengyuan
    Zhao, Runchu
    Jia, Yunfei
    Li, Linjie
    Bai, Bin
    Hu, Ziliang
    Hu, Shixiong
    Niu, Sheng
    Hu, Yu
    Liu, Honghui
    Liu, Bo
    Cui, Kaige
    Li, Weiwei
    Zhao, Xin
    Liu, Kefang
    Qi, Jianxun
    Wang, Qihui
    Gao, George Fu
    IMMUNITY, 2022, 55 (08) : 1501 - +
  • [24] The hinge-engineered IgG1-IgG3 hybrid subclass IgGh47 potently enhances Fc-mediated function of anti-streptococcal and SARS-CoV-2 antibodies
    Izadi, Arman
    Karami, Yasaman
    Bratanis, Eleni
    Wrighton, Sebastian
    Khakzad, Hamed
    Nyblom, Maria
    Olofsson, Berit
    Happonen, Lotta
    Tang, Di
    Sundwall, Martin
    Godzwon, Magdalena
    Chao, Yashuan
    Toledo, Alejandro Gomez
    Schmidt, Tobias
    Ohlin, Mats
    Nilges, Michael
    Malmstrom, Johan
    Bahnan, Wael
    Shannon, Oonagh
    Malmstrom, Lars
    Nordenfelt, Pontus
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [25] Computational study of novel inhibitory molecule, 1-(4-((2S,3S)-3-amino-2hydroxy-4-phenylbutyl)piperazin-1-yl)-3-phenylurea, with high potential to competitively block ATP binding to the RNA dependent RNA polymerase of SARS-CoV-2 virus
    Sharma, Prem Prakash
    Kumar, Sumit
    Srivastava, Sukrit
    Srivastava, Mitul
    Jee, Babban
    Gorobets, Nikolay Yu
    Kumar, Dhruv
    Kumar, Mukesh
    Asthana, Shailendra
    Zhang, Peng
    Poonam
    Zoltner, Martin
    Rathi, Brijesh
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (20): : 10162 - 10180
  • [26] Computational study of novel inhibitory molecule, 1-(4-((2S,3S)-3-amino-2-hydroxy-4-phenylbutyl)piperazin-1-yl)-3-phenylurea, with high potential to competitively block ATP binding to the RNA dependent RNA polymerase of SARS-CoV-2 virus
    Sharma, Prem Prakash
    Kumar, Sumit
    Srivastava, Sukrit
    Srivastava, Mitul
    Jee, Babban
    Gorobets, Nikolay Yu
    Kumar, Dhruv
    Kumar, Mukesh
    Asthana, Shailendra
    Zhang, Peng
    Poonam
    Zoltner, Martin
    Rathi, Brijesh
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021,
  • [27] 1H, 13C, and 15N backbone chemical shift assignments of the nucleic acid-binding domain of SARS-CoV-2 non-structural protein 3e
    Sophie M. Korn
    Karthikeyan Dhamotharan
    Boris Fürtig
    Martin Hengesbach
    Frank Löhr
    Nusrat S. Qureshi
    Christian Richter
    Krishna Saxena
    Harald Schwalbe
    Jan-Niklas Tants
    Julia E. Weigand
    Jens Wöhnert
    Andreas Schlundt
    Biomolecular NMR Assignments, 2020, 14 : 329 - 333
  • [28] 1H, 13C, and 15N backbone chemical shift assignments of the nucleic acid-binding domain of SARS-CoV-2 non-structural protein 3e
    Korn, Sophie M.
    Dhamotharan, Karthikeyan
    Fuertig, Boris
    Hengesbach, Martin
    Loehr, Frank
    Qureshi, Nusrat S.
    Richter, Christian
    Saxena, Krishna
    Schwalbe, Harald
    Tants, Jan-Niklas
    Weigand, Julia E.
    Woehnert, Jens
    Schlundt, Andreas
    BIOMOLECULAR NMR ASSIGNMENTS, 2020, 14 (02) : 329 - 333
  • [29] (2E)-2-(4-ethoxybenzylidene)-3,4-dihydro-2H-naphthalen-1-one single crystal: Synthesis, growth, crystal structure, spectral characterization, biological evaluation and binding interactions with SARS-CoV-2 main protease
    Afsar, N.
    Jonathan, D. Reuben
    Revathi, B. K.
    Satheesh, Dhurairaj
    Manivannan, S.
    JOURNAL OF MOLECULAR STRUCTURE, 2021, 1244
  • [30] Effects of a booster dose of BNT162b2 on spike-binding antibodies to SARS-CoV-2 Omicron BA.2, BA.3, BA.4 and BA.5 subvariants in infection-na?ve and previously-infected individuals
    Kuzel, Timothy G.
    Fu, Jia
    Anderson, Mark
    Stec, Michael
    Boler, Michael
    Behun, Dylan
    Gosha, Amy
    Cloherty, Gavin
    Landay, Alan
    Moy, James
    VACCINE, 2023, 41 (04) : 879 - 882
1234